BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 15790953)

  • 1. Targeted disruption of TGF-beta-Smad3 signaling leads to enhanced neointimal hyperplasia with diminished matrix deposition in response to vascular injury.
    Kobayashi K; Yokote K; Fujimoto M; Yamashita K; Sakamoto A; Kitahara M; Kawamura H; Maezawa Y; Asaumi S; Tokuhisa T; Mori S; Saito Y
    Circ Res; 2005 Apr; 96(8):904-12. PubMed ID: 15790953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of Smad3-dependent TGF-beta signal in vascular response to injury.
    Yokote K; Kobayashi K; Saito Y
    Trends Cardiovasc Med; 2006 Oct; 16(7):240-5. PubMed ID: 16980181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Essential role for Smad3 in regulating MCP-1 expression and vascular inflammation.
    Feinberg MW; Shimizu K; Lebedeva M; Haspel R; Takayama K; Chen Z; Frederick JP; Wang XF; Simon DI; Libby P; Mitchell RN; Jain MK
    Circ Res; 2004 Mar; 94(5):601-8. PubMed ID: 14752027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial NO synthase deficiency promotes smooth muscle progenitor cells in association with upregulation of stromal cell-derived factor-1alpha in a mouse model of carotid artery ligation.
    Zhang LN; Wilson DW; da Cunha V; Sullivan ME; Vergona R; Rutledge JC; Wang YX
    Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):765-72. PubMed ID: 16456092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unique and redundant roles of Smad3 in TGF-beta-mediated regulation of long bone development in organ culture.
    Alvarez J; Serra R
    Dev Dyn; 2004 Aug; 230(4):685-99. PubMed ID: 15254903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smad3 null mice display more rapid wound closure and reduced scar formation after a stab wound to the cerebral cortex.
    Wang Y; Moges H; Bharucha Y; Symes A
    Exp Neurol; 2007 Jan; 203(1):168-84. PubMed ID: 16996058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smad3 has a critical role in TGF-beta-mediated growth inhibition and apoptosis in colonic epithelial cells.
    Mithani SK; Balch GC; Shiou SR; Whitehead RH; Datta PK; Beauchamp RD
    J Surg Res; 2004 Apr; 117(2):296-305. PubMed ID: 15047135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smad3 in the mammary epithelium has a nonredundant role in the induction of apoptosis, but not in the regulation of proliferation or differentiation by transforming growth factor-beta.
    Yang YA; Tang B; Robinson G; Hennighausen L; Brodie SG; Deng CX; Wakefield LM
    Cell Growth Differ; 2002 Mar; 13(3):123-30. PubMed ID: 11959813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stem cell factor deficiency is vasculoprotective: unraveling a new therapeutic potential of imatinib mesylate.
    Wang CH; Anderson N; Li SH; Szmitko PE; Cherng WJ; Fedak PW; Fazel S; Li RK; Yau TM; Weisel RD; Stanford WL; Verma S
    Circ Res; 2006 Sep; 99(6):617-25. PubMed ID: 16931795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concentration-dependent bifunctional effect of TGF-beta 1 on immunoglobulin production: a role for Smad3 in IgA production in vitro.
    McKarns SC; Letterio JJ; Kaminski NE
    Int Immunopharmacol; 2003 Dec; 3(13-14):1761-74. PubMed ID: 14636827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response.
    Ashcroft GS; Yang X; Glick AB; Weinstein M; Letterio JL; Mizel DE; Anzano M; Greenwell-Wild T; Wahl SM; Deng C; Roberts AB
    Nat Cell Biol; 1999 Sep; 1(5):260-6. PubMed ID: 10559937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Smad3 loss confers resistance to the development of trinitrobenzene sulfonic acid-induced colorectal fibrosis.
    Latella G; Vetuschi A; Sferra R; Zanninelli G; D'Angelo A; Catitti V; Caprilli R; Flanders KC; Gaudio E
    Eur J Clin Invest; 2009 Feb; 39(2):145-56. PubMed ID: 19200168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The loss of Smad3 results in a lower rate of bone formation and osteopenia through dysregulation of osteoblast differentiation and apoptosis.
    Borton AJ; Frederick JP; Datto MB; Wang XF; Weinstein RS
    J Bone Miner Res; 2001 Oct; 16(10):1754-64. PubMed ID: 11585338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temporal and spatial characterization of cellular constituents during neointimal hyperplasia after vascular injury: Potential contribution of bone-marrow-derived progenitors to arterial remodeling.
    Shoji M; Sata M; Fukuda D; Tanaka K; Sato T; Iso Y; Shibata M; Suzuki H; Koba S; Geshi E; Katagiri T
    Cardiovasc Pathol; 2004; 13(6):306-12. PubMed ID: 15556776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proliferative activity and alpha-smooth muscle actin expression in cultured rat aortic smooth muscle cells are differently modulated by transforming growth factor-beta 1 and heparin.
    Orlandi A; Ropraz P; Gabbiani G
    Exp Cell Res; 1994 Oct; 214(2):528-36. PubMed ID: 7925646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atrial natriuretic peptide inhibits transforming growth factor beta-induced Smad signaling and myofibroblast transformation in mouse cardiac fibroblasts.
    Li P; Wang D; Lucas J; Oparil S; Xing D; Cao X; Novak L; Renfrow MB; Chen YF
    Circ Res; 2008 Feb; 102(2):185-92. PubMed ID: 17991884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of Smad signaling enhances collagenase-3 (MMP-13) expression and invasion of head and neck squamous carcinoma cells.
    Leivonen SK; Ala-Aho R; Koli K; Grénman R; Peltonen J; Kähäri VM
    Oncogene; 2006 Apr; 25(18):2588-600. PubMed ID: 16407850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective reduction of fibrotic markers in repairing corneas of mice deficient in Smad3.
    Stramer BM; Austin JS; Roberts AB; Fini ME
    J Cell Physiol; 2005 Apr; 203(1):226-32. PubMed ID: 15521071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted disruption of Smad3 confers resistance to the development of dimethylnitrosamine-induced hepatic fibrosis in mice.
    Latella G; Vetuschi A; Sferra R; Catitti V; D'Angelo A; Zanninelli G; Flanders KC; Gaudio E
    Liver Int; 2009 Aug; 29(7):997-1009. PubMed ID: 19422482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-beta.
    Yang X; Letterio JJ; Lechleider RJ; Chen L; Hayman R; Gu H; Roberts AB; Deng C
    EMBO J; 1999 Mar; 18(5):1280-91. PubMed ID: 10064594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.